[Correspondence] Research misconduct and the INTERGROWTH-21st study

We respectfully take issue with the Comment published in February, 2017, by members of The Lancet's editorial staff stating that WHO's judgment of misconduct regarding the Oxford INTERGROWTH-21st study was unproven.1 –3 We are saddened by the fact that they base their conclusion on limited and biased material and simply dismiss the case as rivalry. As members of the WHO Fetal Growth research group and a former WHO external expert not associated with that trial but with evidence that WHO initially refused to he ar, we wish to note the following.
Source: LANCET - Category: General Medicine Authors: Tags: Correspondence Source Type: research